Aptamers: Selected oligonucleotides for therapy

Current Opinion in Molecular Therapeutics

Volumn 2, Issue 3, 2000, Pages 318-324

  Toulmé, Jean Jacques ^a,b  

^a INSERM   (France)

^b CNRS   (France)

Author keywords

Gene therapy; In vitro selection; Modified oligonucleotides; RNA structure; SELEX

Indexed keywords

DNA SEQUENCE; DRUG DESIGN; GENE EXPRESSION REGULATION; GENE THERAPY; HUMAN; MOLECULAR INTERACTION; MOLECULAR RECOGNITION; NONHUMAN; REVIEW; RNA SEQUENCE; RNA STRUCTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; BASE SEQUENCE; GENE EXPRESSION; GENE LIBRARY; GENE THERAPY; HUMANS; OLIGONUCLEOTIDES; OLIGORIBONUCLEOTIDES; TOXINS, BIOLOGICAL; VIRAL PROTEINS;

EID: 0033948628     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Ellington AD, Szostak JW: In vitro selection of RNA molecules that bind specific ligands. Nature (1990) 346:818-822.
2. Tuerk C, Gold L: Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science (1990) 249:505-510.
3. Osborne SE, Ellington AE: Nucleic acid selection and the challenge of combinatorial chemistry. Chem Rev (1997) 97:349-370.
4. Gold L, Polisky B, Uhlenbeck O, Yarus M: Diversity of oligonucleotide functions. Ann Rev Biochem (1995) 64:763-797.
5. Famulok M: Oligonucleotide aptamers that recognize small molecules. Curr Opin Struct Biol (1999) 9:324-329.
6. Hermann T, Patel DJ: Adaptive recognition by nucleic acid aptamers. Science (2000) 287:820-825.
7. Wilson DS, Szostak JW: In vitro selection of functional nucleic acids. Annu Rev Biochem (1999) 68:611-647.
8. Jayasena SD: Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin Chem (1999) 45:1628-1650.
9. Bock LC, Griffin LC, Latham JA, Vermass EH, Toole JJ: Selection of single stranded DNA molecules that bind and inhibit human thrombin. Nature (1992) 355:564-566.
10. Griffin LC, Tidmarsh GF, Bock LC, Toole JJ, Keung LLK: In vivo anticoagulant properties of a novel nucleotide-based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits. Blood (1993) 81:3271-3276.
11. Allen P, Wortand S, Gold L: Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool. Virology (1995) 209:327-336.
12. Symensma TL, Giver L, Zapp M, Takle GB, Ellington AD: RNA aptamer selected to bind human immunodeficiency virus type 1 are rev responsive in vitro. J Virol (1996) 70:179-187.
13. Kumar PKR, Machida K, Urvil PT, Kakiuchi N, Vishnuvardhan D, Shimotonno K, Taira K, Nishikawa S: Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology (1997) 237:270-282.
14. Baskerville S, Zapp M, Ellington AD: Anti-Rex aptamers as mimics of the Rex-binding element. J Virol (1999) 73:4962-4971.
15. Lochrie MA, Waugh S, Pratt DG, Clever J, Parslow TG, Polisky B: In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 Gag polyprotein. Nucleic Acids Res (1997) 25:2902-2910.
16. Clever JL, Taplitz RA, Lochrie MA, Polisky B, Parslow TG: A heterologous, high-affinity RNA ligand for human immunodeficiency virus Gag protein has RNA packaging activity. J Virol (2000) 74:541-546.
17. Schroeder R, Waldsich C, Wank H: Modulation of RNA function by aminoglycoside antibiotics. EMBO J (2000) 19:1-9.
18. Jiang LC, Patel DJ: Solution structure of the tobramycin-RNA aptamer complex. Nature Struct Biol (1998) 5:769-774.
19. Jiang L, Majumdar A, Hu W, Jaishree TJ, Xu W, Patel DJ: Saccharide-RNA recognition in a complex formed between neomycin B and an RNA aptamer. Structure Fold Des (1999) 7:817-827.
20. Wang Y, Rando RR: Specific binding of aminoglycoside antibiotics to RNA. Chem Biol (1995) 2:281-290.
21. Wallis MG, vonAhsen U, Schroeder R, Famulok M: A novel RNA motif for neomycin recognition. Chem Biol (1995) 2:543-552.
22. Hesselberth JR, Miller D, Robertus J, Ellington AD: In vitro selection of RNA molecules that inhibit the activity of ricin α-chain. J Biol Chem (2000) 275:4937-4942.
23. Hirao I, Madin K, Endo Y, Yokoyama S, Ellington AD: RNA aptamers that bind to and inhibit the ribosome-inactivating protein, pepocin. J Biol Chem (2000) 275:4943-4948.
24. Werstuck G, Green MR: Controlling gene expression in living cells through small molecule-RNA interactions. Science (1998) 282:296-298.
25. Haller AA, Samow P: In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules. Proc Natl Acad Sci USA (1997) 94:8521-8526.
26. Pei D, Ulrich HD, Schultz PG: A combinatorial approach toward DNA recognition. Science (1991) 253:1408-1411.
27. Mishra RK, Le Tinévez R, Toulmé JJ: Targeting nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection. Proc Natl Acad Sci USA (1996) 93:10679-10684.
28. Hardenbol P, van Dyke MW: Sequence specificity of triplex DNA formation: Analysis by a combinatorial approach, restriction endonuclease protection selection and amplification. Proc Natl Acad Sci USA (1996) 93:2811-2816.
29. Soukup GA, Ellington AD, Maher U: Selection of RNAs that bind to duplex DNA at neutral pH. J Mol Biol (1996) 259:216-228.
30. Boiziau C, Dausse E, Yurchenko L, Toulmé JJ: DNA aptamers selected against the HIV-1 TAR RNA element form RNA/ DNA kissing complexes. J Biol Chem (1999) 274:12730-12737.
31. Ducongé F, Toulmé JJ: In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1. RNA (1999) 5:1605-1614.
32. Scarabino D, Crisari A, Lorenzini S, Williams K, Tocchini-Valentini GP: tRNA prefers to kiss. EMBO J (1999) 18:4571-4578.
33. Engels JW, Uhlmann E: Chemistry of oligonucleotides. In: Pharmaceutical Aspects of Oligonucleotides. Couvreur P, Malvy C (Eds), Taylor & Francis, London (2000):65-78.
34. Eaton BE: The joys of in vitro selection: Chemically dressing oligonucleotides to satiate protein targets. Curr Opin Chem Biol (1997) 1:10-16.
35. He GX, Williams JP, Postich MJ, Swaminathan S, Shea RG, Terhorst T, Law VS, Mao CT, Sueoka C, Coutre S, Bischofberger N: In vitro and in vivo activities of oligodeoxynucleotide-based thrombin inhibitors containing neutral formacetal linkages. J Med Chem (1998) 41:4224-4231.
36. He GX, Krawczyk SH, Swaminathan S, Shea RG, Dougherty JP, Terhorst T, Law VS, Griffin LC, Coutre S, Bischofberger N: N-2- and C-8-substituted oligodeoxynucleotides with enhanced thrombin inhibitory activity in vitro and in vivo. J Med Chem (1998) 41:2234-2242.
37. Eaton BE, Gold L, Hicke BJ, Janjic N, Jucker FM, Sebesta DP, Tarasow TM, Willis MC, Zichi DA: Post-SELEX combinatorial optimization of aptamers. Bioorg Med Chem (1997) 5:1087-1096.
38. Klussmann S, Nolte A, Bald R, Erdmann VA, Furste JP: Mirror-image RNA that binds D-adenosine. Nature Biotechnol (1996) 14:1112-1115.
39. Williams KP, Liu X-H, Schumacher TNM, Lin HY, Ausiello DA, Kim PS, Bartel DP: Bioactive and nuclease-resistant I-DNA ligand of vasopressin. Proc Natl Acad Sci USA (1997) 94:11285-11290.
40. Davis KA, Lin Y, Abrams B, Jayasena SD: Staining of cell surface human CD4 with 2′-F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Res (1998) 26:3915-3924.
41. Pagratis N, Bell C, Chang Y, Jennings S, Fitzwater T, Jellinek D, Dang C: Potent 2′-amino-, and 2′-fluoro-2′-deoxyribonucleotide RNA inhibitors of keratinocyte growth factor. Nature Biotechnol (1997) 15:68-73.
42. Biesecker G, Dihel L, Enney K, Bendele RA: Derivation of RNA aptamer inhibitors of human complement C5. Immunopharmacology (1999) 42:219-230.
43. Pan W, Craven RB, Qui Q, Wilson CB, Wills JW, Golovine S, Wang JF: Isolation of virus-neutralizing RNAs from a large pool of random sequences. Proc Natl Acad Sci USA (1995) 92:11509-11513.
44. Morris KN, Jensen KB, Julin CM, Weil M, Gold L: High affinity ligands from in vitro selection: Complex targets. Proc Natl Acad Sci USA (1998) 95:2902-2907.
45. Homann M, Geringer HU: Combinatorial selection of high affinity RNA ligands to live African trypanosomes. Nucleic Acids Res (1999) 27:2006-2014.
46. Hicke BJ, Watson SR, Koenig A, Lynott CK, Bargatze RF, Chang YF, Ringquist S, Moon-McDermot L, Jennings S, Fitzwater T, Han HL, Varki N, Albinana I, Willis MC, Varki A, Parma D: DNA aptamers block L-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice. J Clin Invest (1996) 98:2688-2692.
47. Bless NM, Smith D, Charlton J, Czermak BJ, Schmal H, Friedl HP, Ward PA: Protective effects of an aptamer inhibitor of neutrophil elastase in lung inflammatory injury. Curr Biol (1997) 7:877-880.
48. Shi H, Hoffman BE, Us JT: RNA aptamers as effective protein antagonists in a multicellular organism. Proc Natl Acad Sci USA (1999) 96:10033-10038.
49. Floege J, Ostendorf T, Janssen U, Burg M, Radeke HH, Vargeese C, Gill SC, Green LS, Janjic N: Novel approach to specific growth factor inhibition in vivo - antagonism of platelet-derived growth factor in glomerulonephritis by aptamers. Am J Pathol (1999) 154:169-179.
50. Green L, Jellinek D, Jenison R, Ostman A, Heldin CH, Janjic N: Inhibitory DNA ligands to platelet-derived growth factor β-chain. Biochemistry (1996) 35:14413-14424.
51. Green LS, Jellinek D, Bell C, Beebe LA, Feistner BD, Gill SC, Jucker FM, Janjic N: Nuclease resistant nucleic acid ligands to vascular permeability factor/vascular endothelial growth factor. Chem Biol (1995) 2:683-695.
52. Ruckman J, Green LS, Beeson J, Waugh S, Gillette WL, Henninger DD, Claesson-Welsh L, Janjic N: 2′-Fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF165). Inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain. J Biol Chem (1998) 273:20556-20567.
53. Tucker CE, Chen, LS, Judkins MB, Farmer JA, Gill SC, Drolet DW: Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX-1838) in rhesus monkeys. J Chromatogr B Biomed Sci Appl (1999) 732:203-212.
54. Wilson WD, Li K: Targeting RNA with small molecules. Curr Med Chem (2000) 7:73-98.
55. Konopka K, Duzgunes N, Rossi J, Lee NS: Receptor ligand-facilitated cationic liposome delivery of anti-HIV-1 Rev-binding aptamer and ribozyme DNAs. J Drug Target (1998) 5:247-259.
56. Bruno JG, Kiel JL: In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection. Biosens Bioelectron (1999) 14:457-464.
57. Drolet DW, Jenison RD, Smith DE, Pratt D, Hicke BJ: A high-throughput platform for systematic evolution of ligands by exponential enrichment (SELEX). Comb Chem High Throughput Screen (1999) 2:271-278.